| 
			
			 The method, known as endometrial scratching, involves taking a 
			flexible tube that lets gynecologists collect tissue samples in the 
			uterus and using it to create a small scratch in the lining of the 
			uterus a month or so before a fertilized egg is transferred. 
 The scratch was supposed to somehow create inflammation or affect 
			the immune system in a way that would make it easier for the egg to 
			attach.
 
 But the new randomized, controlled trial of the technique, which was 
			performed on half of the 1,364 women included in the study, showed 
			that unscratched women were just as likely to get pregnant and 
			deliver a baby as those who received the scratch.
 
 In fact, the success rates in the two groups were identical: 180 
			live births in the 690 women (26.1%) in the endometrial-scratch 
			group and 176 among the 674 women (26.1%) in the control group, the 
			study team reports in the New England Journal of Medicine.
 
			
			 
			
 Although the technique was unproven - earlier studies supporting its 
			use were small or not done well - a survey in the UK, Australia and 
			New Zealand showed that 83 percent of fertility doctors were doing 
			it, and typically charging $200 to $500 for the futile procedure
 
 "We would recommend that clinics stop offering this," lead study 
			author Sarah Lensen told Reuters Health in a telephone interview.
 
 "This unequivocally shows there is no place for this in our practice 
			for treating infertility patients," Dr. Christos Coutifaris, past 
			president of the American Society for Reproductive Medicine, told 
			Reuters Health by phone.
 
 Even when the researchers looked at subsets of patients who, in 
			theory, might benefit, "there's not even a trend" indicating that 
			scratching improves the success rate, said Coutifaris, of the 
			University of Pennsylvania's Perelman School of Medicine in 
			Philadelphia, who wasn't involved in the study.
 
 If nothing else, abandoning the technique will save women some pain. 
			On a scale of 1 to 10, with 10 being the worst pain, half of the 
			participants in the study said the scratching technique rated a 3.5 
			or higher, and that was after they had taken pain medication first.
 
 The pain was so great for one woman, she went to the emergency 
			department. Seven fainted, felt dizzy or experienced nausea after 
			the scratch. There were two cases of excessive bleeding. The 
			technique did not appear to cause any infections.
 
			
            [to top of second column] | 
 
			Lensen said the practice of endometrial scratching began around 2005 
			after a group of fertility doctors noticed that women who had failed 
			previous IVF attempts seemed more likely to get pregnant after the 
			doctors took tissue biopsies to help figure out why their fertilized 
			eggs weren't implanting. The idea has actually been around since the 
			1970s, Coutifaris noted. 
			The new study was done at 13 centers in five countries, with women 
			recruited over a three-year period. For 25 percent of the 
			volunteers, it was at least their third attempt to have a child via 
			in vitro techniques.
 The Lensen team also looked at whether scratching affected the odds 
			of having twins, a miscarriage or a tubal pregnancy. It did not.
 
			Nor did it matter whether the implanted embryos were fresh or had 
			been frozen.
 "Neither the days between endometrial scratch and embryo transfer 
			nor pain during the procedure was a predictor of live birth in the 
			endometrial-scratch group," the researchers report. "There was also 
			no evidence of any benefit from endometrial scratching among women 
			in whom implantation had failed at least twice or among women in 
			whom it had failed no more than once."
 
 The scratching was typically done 35 days before the embryo was 
			transferred into the uterus, but doctors had wide latitude over the 
			timing.
 
 Because the study showed no benefit among women in any of the 
			subgroups and was done at centers in different countries, "the 
			results of this trial should be trusted," Drs. Ben Mol of Monash 
			University in Australia and Kurt Barnhart, also of Perleman, write 
			in an accompanying editorial.
 
 SOURCE: https://bit.ly/2FESdVv The New England Journal of Medicine, 
			online January 23, 2019.
 
			[© 2019 Thomson Reuters. All rights 
				reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content. 
			
			 |